Elite Pharmaceuticals Inc (ELTP): Why did Lannett sign a new 2-year agreem...

Send PM Follow Ignore

Re: jour_trader post# 366134

Sunday, 02/20/2022 7:27:48 PM

Sunday, February 20, 2022 7:27:48 PM

Why did Lannett sign a new 2-year agreement with Elite knowing they were scheduled to receive their own Adderall XR approval the VERY NEXT MONTH?

MAKE ELITE GREAT AGAIN!

Keep Last Read

Replies (1) Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2024 08:47:43 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/27/2024 08:30:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 09:16:11 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:05:53 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:07:15 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:30:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM

InvestorsHub NewsWire

Only $200 per official company press release!